Use this url to cite publication: https://hdl.handle.net/20.500.12512/64486
Alfacalcidol in the treatment of osteoporosis
Type of publication
Straipsnis (apžvalginis, informacinis, enciklopedinis) / Article (survey, information, encyclopedic) (S8)
Title
Alfacalcidol in the treatment of osteoporosis
A. Krasauskienė, L. Lašas, D. Lašienė
Publisher (trusted)
Kauno medicinos universiteto leidykla
Date Issued
Date |
---|
1999-12-20 |
Extent
p. 165-165.
Is part of
Annual report'98 / Kaunas University of Medicine. Kaunas : Kauno medicinos universiteto leidykla, 1999.
Version
Originalus / Original
Description
Institute of Endocrinology
Abstract (en)
To evaluate the efficacy and safety of alfacalcidol, we conducted a two-years study in 32 women who had clinical and roentgenological signs of osteoporosis. All randomly assigned women received treatment with One Alpha (alfacalcidol) 0.25 mg twice a day (LEO Pharmaceutical Products A/S Denmark). The daily calcium intake was about 1,000 mg in the diet mainly, except 8 women who got tablets. [...].
Type of document
type::text::journal::journal article::research article
Other Identifier(s)
(LSMU ALMA)990000480670107106
Coverage Spatial
Lietuva / Lithuania (LT)
Language
Anglų / English (en)